• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a new cancer chemotherapy by using curcumin analogs

Research Project

Project/Area Number 22501041
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Clinical oncology
Research InstitutionAkita University

Principal Investigator

SHIBATA Hiroyuki  秋田大学, 大学院・医学系研究科, 教授 (50260071)

Co-Investigator(Kenkyū-buntansha) IWABUCHI Yoshiharu  東北大学, 大学院・薬学研究科, 教授 (20211766)
UEHARA Yoshihiko  東北大学, 大学院・医学研究科, 教授 (30223499)
OHORI Hisatsugu  東北大学, 医学部附属病院, 助教 (30431555)
Project Period (FY) 2010 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywordsクルクミン / 抗腫瘍活性 / NF-κBシグナル伝達阻害 / がん幹細胞 / 誘導体 / 腫瘍血管阻害活性 / 転移抑制活性 / 発がん予防活性 / マルチターゲット / がん治療 / ミエローマ / 血管新生阻害 / 浸潤抑制 / 抗がん剤 / 放射線防護作用
Research Abstract

We have developed 86 types of new curcumin analogs, successfully resulting in getting several analogs with higher anti-cancer potential. These analogs are effective for various cancers including colorectal cancer stem cells. They are shown to be NF-κB inhibitors. In animal models, they were also shown to be effective for some cancers such as gastric cancers and colorectal cancer stem cells. These data indicate that new curcumin analogs have some potential to treat cancers.

Report

(4 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Annual Research Report
  • 2010 Annual Research Report
  • Research Products

    (47 results)

All 2013 2012 2011 2010 Other

All Journal Article (14 results) (of which Peer Reviewed: 8 results) Presentation (21 results) Book (5 results) Remarks (5 results) Patent(Industrial Property Rights) (2 results) (of which Overseas: 2 results)

  • [Journal Article] A Phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients2013

    • Author(s)
      Kanai M
    • Journal Title

      Cancer Chemotherapy and Pharmacology

      Volume: on line Issue: 6 Pages: 1-10

    • DOI

      10.1007/s00280-013-2151-8

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis2011

    • Author(s)
      Sato, A., Kudo, C., Yamakoshi, H., Uehara, Y., Ohor,i H., Ishioka, C., Iwabuchi, Y. Shibata H.
    • Journal Title

      Cancer Science

      Volume: 102(5) Pages: 1045-1051

    • NAID

      10029293736

    • Related Report
      2012 Final Research Report
  • [Journal Article] Targeting colon cancer stem cells using a new curcumin analogue2011

    • Author(s)
      Lin L, Liu Y, Li H, Li P-K, Shibata H, Iwabuchi Y, Lin J.
    • Journal Title

      GO-Y030. Br J Cancer

      Volume: 105 Pages: 212-220

    • Related Report
      2012 Final Research Report
  • [Journal Article] Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo2011

    • Author(s)
      Kudo C, Yamakoshi H, Sato A, Nanjo H, Ohori H, Ishioka C, Iwabuchi Y, Shibata H.
    • Journal Title

      BMC Pharmacology

      Volume: 28

    • Related Report
      2012 Final Research Report
  • [Journal Article] Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents for multiple myeloma with enhanced abilities2011

    • Author(s)
      Kudo C, Yamakoshi H, Sato A, Ohori H, Ishioka C, Iwabuchi Y, Shibata H.
    • Journal Title

      Anticancer Research

      Volume: 31(11) Pages: 3719-3726

    • Related Report
      2012 Final Research Report
  • [Journal Article] Targeting colon cancer stem cells using a new curcumin analogue, G0-Y0302011

    • Author(s)
      H.Shibata, Y Iwabuchi, et al.
    • Journal Title

      Br J Cancer

      Volume: 105 Pages: 212-220

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Curcumin analog G0-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis2011

    • Author(s)
      H.Shibata, Y Iwabuchi, et al.
    • Journal Title

      Cancer science

      Volume: 102 Pages: 1045-1051

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Synthesis of 86 species of 1,5-diaryl-3-oxo-1,4-pentadienes analogs of curcumin can yield a good lead in vivo2011

    • Author(s)
      H.Shibata, Y Iwabuchi, et al.
    • Journal Title

      BMC Pharmacology

      Volume: 11 Issue: 1

    • DOI

      10.1186/1471-2210-11-4

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Novel curcumin analogs, G0-Y030 and G0-Y078, are multi-targeted agents for multiple myeloma with enhanced abilities2011

    • Author(s)
      H.Shibata, Y Iwabuchi, et al.
    • Journal Title

      Anticancer Research

      Volume: 31 Pages: 3719-3726

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] The curcumin analog GO-Y030 is a novel inhibitor of IKKB that suppresses NF-KB signaling and induces apoptosis.2011

    • Author(s)
      Shibata H, Iwabuchi Y, Uehara Y, Ohori H, et al
    • Journal Title

      Cancer Science

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Phase II study of FOLFOX4 with "wait and go" strategy as first-line treatment for metastatic colorectal cancer2011

    • Author(s)
      Shibata h, et al
    • Journal Title

      Cancer Chemother Pharmacol

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] KSRP/FUBP2 is a binding protein of GO-Y086, a cytotoxic curcumin analogue2010

    • Author(s)
      Yamakoshi, H, Kanoh, N, Kudo, C, Sato, A, Ueda, K, Muroi, M, Kon, S, Satake, M, Ohori, O, Ishioka, C, Oshima, Y, Osada, H, Chiba, N, Shibata H, Iwabuchi, Y.
    • Journal Title

      ACS Medicinal Chemistry Letters

      Volume: 1(6) Pages: 273-276

    • Related Report
      2012 Final Research Report
  • [Journal Article] KSRP/FUBP2 is a binding protein of GO-Y086, a cytotoxic curcumin analogue.2010

    • Author(s)
      Shibata H, Iwabuchi Y, Ohori H, et al
    • Journal Title

      ACS Medicinal Chemistry Letters

      Volume: 1 Pages: 273-276

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A Phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients

    • Author(s)
      Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H
    • Journal Title

      Cancer Chemotherapy and Pharmacology

      Volume: (in press)

    • NAID

      120005477228

    • Related Report
      2012 Final Research Report
  • [Presentation] 新規クルクミン類縁体の血管新生阻害効果の可能性2012

    • Author(s)
      杉山俊輔, 角道祐一, 岩渕好治, 石岡千加史, 柴田浩行
    • Organizer
      第16回日本がん分子標的治療学会
    • Related Report
      2012 Final Research Report
  • [Presentation] クルクミンアナログ(第2弾)抗がん幹細胞活 性と抗トリオパノソーマ活性2012

    • Author(s)
      柴田浩行
    • Organizer
      第11回国際バイオEXPO バイオアカデミックフォーラム~大学・国公立研究所による研究成果発表フォーラム~
    • Related Report
      2012 Final Research Report
  • [Presentation] Phase I study of nanoparticle curcumin, a potential anti-cancer agents with improved bioavailability, for patients with cancer who failed standard chemotherapy2012

    • Author(s)
      Kanai, M., Imaizumi, A., Otsuka, Y., Matsumoto, S., Chiba, T., Nishihira, J., Shibata, H.
    • Organizer
      GAP Annual Conference
    • Related Report
      2012 Final Research Report
  • [Presentation] ゲムシタビンに抵抗性となった膵癌・胆道癌患者に対するナノ化クルクミン療法の第I相臨床試験2012

    • Author(s)
      金井雅史, 森由希子, 西村貴文, 松本繁巳, 柳原一弘, 千葉勉, 波多野悦朗, 川口義弥, 児玉裕三, 西平順, 大塚和令, 柴田浩行
    • Organizer
      第10回日本臨床腫瘍学会学術集会
    • Related Report
      2012 Final Research Report
  • [Presentation] 新規クルクミン誘導体による大腸がん幹細胞増殖抑制効果2012

    • Author(s)
      柴田浩行, 岩渕好治, 大塚和令, 今井源
    • Organizer
      第71回日本癌学会学術総会
    • Related Report
      2012 Final Research Report
  • [Presentation] クルクミンアナログ(第2弾)抗がん幹細胞活性と抗トリオパノソーマ活性2012

    • Author(s)
      柴田浩行
    • Organizer
      BIOtech2012 第11回国際バイオテクノロジー展
    • Place of Presentation
      東京
    • Related Report
      2012 Annual Research Report
  • [Presentation] 新規クルクミン誘導体による大腸がん幹細胞増殖抑制効果2012

    • Author(s)
      柴田浩行
    • Organizer
      第71回日本癌学会学術総会
    • Place of Presentation
      札幌
    • Related Report
      2012 Annual Research Report
  • [Presentation] 新規クルクミン誘導体の血管新生阻害活性2011

    • Author(s)
      柴田浩行
    • Organizer
      第70回日本癌学会
    • Place of Presentation
      名古屋国際会議場
    • Year and Date
      2011-10-29
    • Related Report
      2011 Annual Research Report
  • [Presentation] 新規クルクミン誘導体によるがん薬物療法の開発2011

    • Author(s)
      柴田浩行
    • Organizer
      第10回国際バイオEXPO バイオアカデミックフォーラム
    • Place of Presentation
      東京ビッグサイト
    • Year and Date
      2011-06-29
    • Related Report
      2011 Annual Research Report
  • [Presentation] 新規クルクミン類縁体による抗腫瘍効果の増強とそのメカニズムの検討2011

    • Author(s)
      工藤千枝子, 山越博幸, 大堀久詔, 佐藤温子, 石岡千加史, 岩渕好治, 柴田浩行
    • Organizer
      第135回東北大学加齢医学研究所集談会
    • Place of Presentation
      仙台市
    • Year and Date
      2011-01-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] 新規クルクミン誘導体の血管新生阻害活性2011

    • Author(s)
      柴田浩行,栗山正, 大塚和令, 岩渕好治, 田中正光
    • Organizer
      第70回日本癌学会学術総会
    • Related Report
      2012 Final Research Report
  • [Presentation] 新規クルクミン誘導体によるがん薬物療法の開発2011

    • Author(s)
      柴田浩行
    • Organizer
      第10回国際バイオEXPO バイオアカデミックフォーラム~大学・国公立研究所による研究成果発表フォーラム~
    • Related Report
      2012 Final Research Report
  • [Presentation] 個別症例における大腸癌原発巣/転移巣別のEGFRシグナル伝達系遺伝子変異の解析2010

    • Author(s)
      大塚和令, 南條博, 宮澤秀彰, 打波宇, 吉岡政人, 渡辺剛, 阿部ゆき, 山本雄造, 柴田浩行
    • Organizer
      第48回日本癌治療学会学術集会
    • Place of Presentation
      京都市
    • Year and Date
      2010-10-30
    • Related Report
      2010 Annual Research Report
  • [Presentation] 秋田大学病院食道癌Cancer Boardの現状と課題2010

    • Author(s)
      本山悟, 丸山起誉幸, 宇佐美修悦, 大西洋英, 神万里夫, 眞嶋浩聡, 松橋保, 安倍明, 石山公一, 古賀誠, 柴田浩行, 大塚和令, 比内雄大, 小川純一
    • Organizer
      第48回日本癌治療学会学術集会
    • Place of Presentation
      京都市
    • Year and Date
      2010-10-29
    • Related Report
      2010 Annual Research Report
  • [Presentation] 東北大学病院腫瘍内科のセカンドオピニオン外来の現状と役割2010

    • Author(s)
      加藤俊介, 森隆弘, 砦田浩行, 下平秀樹, 角道祐一, 大塚和令, 高橋信, 高橋雅信, 大堀久詔, 秋山聖子, 佐々木厳, 古山美智子, 本間とし子, 原沙絵, 石岡千加史
    • Organizer
      第48回日本癌治療学会学術集会
    • Place of Presentation
      京都府
    • Year and Date
      2010-10-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] Novel curcumin analogs have anti-tumor potentials against myeloma cells through the suppression of IRF4/MLTM l function2010

    • Author(s)
      Ohori H, Iwabuchi Y, Shibata h, et al
    • Organizer
      69^(th) annual meeting of the Japanese Cancer Association
    • Place of Presentation
      Osaka, Japan
    • Year and Date
      2010-09-24
    • Related Report
      2010 Annual Research Report
  • [Presentation] 2D-DIGEを用いたプロテオーム解析によるクルクミンの標的分子同定2010

    • Author(s)
      近藤久恵, 室井誠, 山越博幸, 叶直樹, 柴田浩行, 岩渕好治, 長田裕之
    • Organizer
      第14回日本がん分子標的治療学会学術集会
    • Place of Presentation
      東京都
    • Year and Date
      2010-07-08
    • Related Report
      2010 Annual Research Report
  • [Presentation] 医学生に対する悪い知らせのコミュニケーション・スキルの教育とその効果に関する検証2010

    • Author(s)
      廣川誠, 丸山起誉幸, 片寄喜久, 佐藤圭子, 豊島至, 柴田浩行
    • Organizer
      第15回日本緩和医療学会学術大会
    • Place of Presentation
      東京都
    • Year and Date
      2010-06-18
    • Related Report
      2010 Annual Research Report
  • [Presentation] 秋田大学医学部における臨床腫瘍学教育への取り組み2010

    • Author(s)
      柴田浩行, 大塚和令
    • Organizer
      第107回日本内科学会総会・講演会
    • Place of Presentation
      東京都
    • Year and Date
      2010-04-10
    • Related Report
      2010 Annual Research Report
  • [Presentation] 2D-DIGEを用いたプロテオーム解析によるクルクミンの標的分子同定2010

    • Author(s)
      近藤久恵, 室井 誠, 山越博幸, 叶 直樹, 柴田浩行, 岩渕好治, 長田 裕之
    • Organizer
      第14回日本がん分子標的治療学会学術集会
    • Related Report
      2012 Final Research Report
  • [Presentation] Novel curcumin analogs have anti-tumor potentials against myeloma cells through the suppression of IRF4/MUM1 function2010

    • Author(s)
      Kudo, C., Yamakoshi, H., Sato, A., Ohori, H., Ishioka, C., Iwabuchi, Y., Shibata, H.
    • Organizer
      第69回日本癌学会学術総会
    • Related Report
      2012 Final Research Report
  • [Book] Curcumin: Biosynthesis, Medicinal Uses and Health Benefits, Nova Science Publishers (NY, U.S.A.)2012

    • Author(s)
      Shibata H, Iwabuchi Y
    • Publisher
      Challenges in Establishing Potent Cancer Chemotherapy using Newly Synthesized 1,5-Diaryl-3-Oxo-1,4-Pentadiene Analogs of Curcumin
    • Related Report
      2012 Final Research Report
  • [Book] Curcumin: Biosynthesis, Medicinal Uses and Health Benefits2012

    • Author(s)
      Shibata H
    • Total Pages
      266
    • Publisher
      Nova Science Publishers (NY, U.S.A.)
    • Related Report
      2012 Annual Research Report
  • [Book] Challenges in Establishing Potent Cancer Chemotherapy using Newly Synthesized 1,5-Diaryl-3-Oxo-1,4-Pentadiene Analogs of Curcumin2012

    • Author(s)
      H.Shibata, Y Iwabuchi
    • Total Pages
      20
    • Publisher
      Nova Science Publishers(in press)
    • Related Report
      2011 Annual Research Report
  • [Book] EBMがん化学療法・分子標的治療法2011-20122010

    • Author(s)
      柴田浩行(分担執筆)
    • Publisher
      中外医学社
    • Related Report
      2010 Annual Research Report
  • [Book] 消化器がん治療最前線一秋田大学医学部の挑戦「秋田県消化器がんフォーラム」2010

    • Author(s)
      大西洋英、柴田浩行、山本雄造
    • Publisher
      秋田魁新報社
    • Related Report
      2010 Annual Research Report
  • [Remarks] 秋田大学大学院臨床腫瘍学講座

    • URL

      http://www.med.akita-u.ac.jp/~medonco/

    • Related Report
      2012 Final Research Report
  • [Remarks] 文部科学省科学研究費新学術領域研究 がん研究分野の特性等を踏まえた支援活動

    • URL

      http://ganshien.umin.jp/public/research/spotlight/shibata/index.html

    • Related Report
      2012 Final Research Report
  • [Remarks] 秋田大学臨床腫瘍学講座

    • URL

      http://www.med.akita-u.ac.jp/~medonco/

    • Related Report
      2012 Annual Research Report
  • [Remarks] 文部科学省 がん研究分野の特性を踏まえた支援活動

    • URL

      http://ganshien.umin.jp/public/research/spotlight/shibata/index.html

    • Related Report
      2012 Annual Research Report
  • [Remarks]

    • URL

      http://www.ysplan.com/auh/cc/achievement.html

    • Related Report
      2010 Annual Research Report
  • [Patent(Industrial Property Rights)] ビス(アリールメチリデン)アセトン化合物、抗癌剤、発癌予防剤、Ki-Ras、ErbB2、c-Myc及びCyclinD1の発現抑制剤、β-カテニン分解剤並びにp53の発現増強剤2012

    • Inventor(s)
      柴田 浩行,岩渕 好治,大堀 久詔,山越 博幸,角道 祐一
    • Industrial Property Rights Holder
      国立大学法人東北大学
    • Filing Date
      2012-08-03
    • Related Report
      2012 Final Research Report
    • Overseas
  • [Patent(Industrial Property Rights)] BIS(ARYLMETHYLIDENE9ACETONE COMPOUND, ANTI-CANCER AGENT, CARCINOGENESIS-PREVENTIVE AGENT, INHIBITOR OF EXPRESSION OF KI-RAS, ERBB2, C-MYC AND CYCLINE D1,β-CATENIN-DEGRADATING AGENT, P53 EXPRESSION ENHANCER2012

    • Inventor(s)
      Hiroyuki Shibata, Yoshiharu Iwabuchi, Hisatsugu Ohori, Hiroyuki Yamakoshi, Yuichi Kakudo
    • Industrial Property Rights Holder
      National University Corporation Tohoku University
    • Filing Date
      2012-05-15
    • Related Report
      2012 Final Research Report
    • Overseas

URL: 

Published: 2010-08-23   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi